Replies to post #1567 on Vascular Biogenics Ltd (VBLT)

[Oren1976]

But ph2 rgbm vb111 we also have 10% durable. I think 2 patients are alive one from the group of sub therapeutic dose and 1 from high dose monotherapy correct me if I m wrong

[gr8db8]

You're comparing apples to oranges. Tocagen's data is from recurrent HGG. VBL is recurrent GBM (grade 4).

I haven't seen the details of the CRs for Tocagen but yes, the reported results look very good. It looks like the FDA has seen something that it liked -- very much.

I would compare VBL against other rGBM treatments only.

[gr8db8]

Look at all of Celldex's CRs in phase 2. Better than VB-111, right?

http://ir.celldex.com/releasedetail.cfm?ReleaseID=809242